Alok Dalal

Alok Dalal joined Jefferies in December of 2022, following 14 years as a senior analyst covering the Indian Healthcare sector at CLSA India, Motilal Oswal and BNP Paribas. Alok began his equity research career in 2005, and has covered telecom, aviation and healthcare sectors. Alok has been ranked in Institutional Investor and Asia Money for his work on Healthcare and received awards from Thomson Reuters for earnings estimation and stock picking

What I am Known For

• Long-term experience having seen the up and down cycle of Healthcare
• Exhaustive coverage across various subs-sectors of Healthcare and Pharma
• Sector knowledge and historical modeling

How I am Different

• Exhaustive coverage of 22 stocks covering various sub-sector of pharma
• Strong channel checks
• Differentiated corporate access

Corporate & Strategic Access

• Healthcare Tour in Delhi (Sept 2025)
• Expert Events: Hospital Pricing in India
• NDRs in US, EU & Asia for Max Health, Global Health, Zydus Life, Entero Health and Piramal Pharma